TelyRx Holdings Inc. faced a notable decline in its stock price during yesterday's trading session.
TelyRx Holdings Inc. saw its stock price fall by 1.18% yesterday, closing at CA$2.52. This decline reflects investor sentiment as the company navigates a challenging market environment.
Advertisement
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$63.82M
52W high
$4.25
52W low
$2.00
1W change
+11.35%
Analyst Price Targets
Based on analyst covering TELY · as of Sep 17, 2026
Wall Street analysts forecast TELY stock price to rise 135.3% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+135.3% Upside
Current Price
C$2.55
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
64.2%
Annualized
90-Day Vol
88.9%
Annualized
Trend (90d)
+25.5%
Annualized drift
90d Mean
C$2.79
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.63 | C$2.11 – C$3.28 |
| 60 trading days | C$2.71 | C$1.98 – C$3.71 |
| 90 trading days | C$2.79 | C$1.90 – C$4.10 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should remain cautious as TelyRx's stock shows signs of volatility, particularly in light of its recent financial performance.
Market Cap of CA$63.8 Million
With a market cap of CA$63.8 million, TelyRx Holdings Inc. remains a small player in the TSX, which may contribute to its stock's susceptibility to fluctuations.
Bull case
Despite the recent drop, TelyRx has reported significant revenue growth in previous quarters. This suggests there’s potential for recovery if the company continues to expand its digital pharmacy services.
Bear case
However, the consistent losses and lack of dividends may deter investors, especially in a market where profitability is increasingly scrutinized.
Understanding TelyRx's Recent Performance
Advertisement
TelyRx Holdings Inc. has been navigating a challenging landscape, with its stock price declining by 1.18% yesterday. This drop highlights the volatility that can accompany smaller market cap companies, particularly in the healthcare sector. Investors should consider the broader market conditions and TelyRx's financial metrics when evaluating their positions.
Financial Health and Future Prospects
While TelyRx reported impressive revenue growth in recent quarters, the company continues to face significant net losses, raising concerns about its long-term viability. The absence of a dividend and a negative profit margin further complicate the investment thesis. For more insights on TelyRx's financial performance, check out their latest quarterly results.
Market Sentiment and Investor Outlook
With a market cap of CA$63.8 million, TelyRx Holdings Inc. remains a relatively small player on the TSX. This size can lead to increased volatility, as seen in yesterday's trading session. Investors should be mindful of these dynamics and consider the potential risks and rewards before making decisions. For further details on TelyRx's stock performance, visit the TelyRx stock page.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
